1 |
Chong AM. Promoting the psychosocial health of the elderly-the role of social workers[J]. Soc Work Health Care, 2007, 44(1-2): 91-109.
|
2 |
Beard JR,Officer A,de Carvalho IA, et al. The Wo-rld report on ageing and health: a policy framework for healthy ageing [J]. Lancet, 2016, 387(10033): 2145-2154.
|
3 |
Suares NC,Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis[J]. Am J Gastroenterol, 2011, 106(9): 1582-1591.
|
4 |
Sanchez MI,Bercik P. Epidemiology and burden of chronic constipation[J]. Can J Gastroenterol, 2011 (25 Suppl B): 11B-15B.
|
5 |
Chang JY,Locke GR 3rd,McNally MA, et al. Impact of functional gastrointestinal disorders on survival in the community[J]. Am J Gastroenterol, 2010, 105(4): 822-832.
|
6 |
O'Hara AM,Shanahan F. The gut flora as a forgotten organ[J]. EMBO Rep, 2006, 7(7): 688-693.
|
7 |
Sommer F,Backhed F. The gut microbiota--masters of host development and physiology[J]. Nat Rev Microbiol, 2013, 11(4): 227-238.
|
8 |
Cani PD,Bibiloni R,Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice[J]. Diabetes, 2008, 57(6): 1470-1481.
|
9 |
Ni J,Wu GD,Albenberg L, et al. Gut microbiota and IBD: causation or correlation?[J]. Nat Rev Gastroenterol Hepatol, 2017, 14(10): 573-584.
|
10 |
Guarner F,Malagelada JR. Gut flora in health and disease[J]. Lancet, 2003, 361(9356): 512-519.
|
11 |
Posserud I,Stotzer PO,Bjornsson ES, et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome[J]. Gut, 2007, 56(6): 802-808.
|
12 |
Lozupone CA,Stombaugh JI,Gordon JI, et al. Dive-rsity, stability and resilience of the human gut microbiota[J]. Nature, 2012, 489(7415): 220-230.
|
13 |
Cho I,Blaser MJ. The human microbiome: at the interface of health and disease[J]. Nat Rev Genet, 2012, 13(4): 260-270.
|
14 |
Bouhnik Y,Neut C,Raskine L, et al. Prospective, randomized, parallel-group trial to evaluate the effects of lactulose and polyethylene glycol-4000 on colonic flora in chronic idiopathic constipation[J]. Aliment Pharmacol Ther, 2004, 19(8): 889-899.
|
15 |
Silk DB,Davis A,Vulevic J, et al. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome[J]. Aliment Pharmacol Ther, 2009, 29(5): 508-518.
|
16 |
Gomez-Arango LF,Barrett HL,Wilkinson SA, et al. Low dietary fiber intake increases Collinsella abundance in the gut microbiota of overweight and obese pregnant women [J]. Gut microbes, 2018, 9(3): 189-201.
|
17 |
Locke GR 3rd,Pemberton JH,Phillips SF. American gastroenterological association medical position statement: guidelines on constipation[J]. Gastroenterology, 2000, 119(6): 1761-1766.
|
18 |
Gallegos-Orozco JF,Foxx-Orenstein AE,Sterler SM, et al. Chronic constipation in the elderly[J]. Am J Gastroenterol, 2012, 107(1): 18-25.
|
19 |
Vandeputte D,Falony G,Vieira-Silva S, et al. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates[J]. Gut, 2016, 65(1): 57-62.
|
20 |
Burton KJ,Rosikiewicz M,Pimentel G, et al. Probiotic yogurt and acidified milk similarly reduce postprandial inflammation and both alter the gut microbiota of healthy, young men[J]. Br J Nutr, 2017, 117(9): 1312-1322.
|
21 |
Closa-Monasterolo R,Ferré N,Castillejo-DeVillasante G, et al. The use of inulin-type fructans improves stool consistency in constipated children. A randomised clinical trial: pilot study[J]. Int J Food Sci Nutr, 2017, 68(5): 587-594.
|
22 |
Roberfroid MB. Prebiotics and probiotics: are they fun-ctional foods?[J]. Am J Clin Nutr, 2000, 71(6 Suppl): 1682S-1687S; discussion 1688S-1690S.
|
23 |
Vandeputte D,Falony G,Vieira-Silva S, et al. Prebiotic inulin-type fructans induce specific changes in the human gut microbiota[J]. Gut, 2017, 66(11): 1968-1974.
|
24 |
Rivière A,Selak M,Lantin D, et al. Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut[J]. Front Microbiol, 2016 (7): 979.
|
25 |
Bothe MK,Maathuis AJH,Bellmann S, et al. Dose-dependent prebiotic effect of lactulose in a computer-controlled in vitro model of the human large intestine [J]. Nutrients, 2017, 9(7): pii: E767.
|
26 |
Sato T,Kusuhara S,Yokoi W, et al. Prebiotic potential of L-sorbose and xylitol in promoting the growth and metabolic activity of specific butyrate-producing bacteria in human fecal culture[J]. FEMS Microbiol Ecol, 2017, 93(1): pii: fiw227. Epub 2016 Nov 2.
|
27 |
Feghali CA,Wright TM. Cytokines in acute and chronic inflammation[J]. Front Biosci, 1997 (2): d12-d26.
|
28 |
Liebregts T,Adam B,Bredack C, et al. Immune activation in patients with irritable bowel syndrome [J]. Gastroenterology, 2007, 132(3): 913-920.
|
29 |
Coskun M,Vermeire S,Nielsen OH. Novel targeted therapies for inflammatory bowel disease[J]. Trends Pharmacol Sci, 2017, 38(2): 127-142.
|
30 |
Rooks MG,Garrett WS. Gut microbiota, metabolites and host immunity[J]. Nat Rev Immunol, 2016, 16(6): 341-352.
|
31 |
Seyedmirzaee S,Hayatbakhsh MM,Ahmadi B, et al. Serum immune biomarkers in irritable bowel syndrome[J]. Clin Res Hepatol Gastroenterol, 2016, 40(5): 631-637.
|
32 |
Hughes PA,Harrington AM,Castro J, et al. Sensory neuro-immune interactions differ between irritable bowel syndrome subtypes[J]. Gut, 2013, 62(10): 1456-1465.
|